Old Web
English
Sign In
Acemap
>
authorDetail
>
Eric Beys
Eric Beys
Internal medicine
Brown adipose tissue
Antagonist
Leukotriene D4
Estrous cycle
2
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An open-label, first-in-human, dose escalation study of a novel CD3-CD123 bispecific T-cell engager administered as a single agent by intravenous infusion in patients with relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high risk myelodysplastic syndrome.
2018
Journal of Clinical Oncology
Nicolas Boissel
Stéphane de Botton
Xavier Thomas
Ercole Rao
Hélène Bonnevaux
Chantal Rubin-Carrez
Stéphane Guerif
Eric Beys
Alice Gosselin
Anne-Laure Bauchet
Valery Novikov
Elma Fernandes
Dmitri Wiederschain
Emanuel A. Palatinsky
Karl Hsu
Paula G. Fraenkel
Show All
Source
Cite
Save
Citations (4)
Subchronic toxicity studies with the leukotriene D4 antagonist RG 12525.
1995
Toxicological Sciences
Marc S. Bonnefoi
Michael F. Kelley
Roger E. Wells
James Sanders
Zaid Jayyosi
Eric Beys
Douglas Kornbrust
John M. Langloss
Show All
Source
Cite
Save
Citations (4)
1